| Website | chengxin.com.tw/i... |
| Phone | 886-2-2507-2960 |
| info@chengxin.com.tw | |
| Employees | |
| Founded | 1990 |
| Description | private equity |
Cheng Xin (CX) Venture Capital Group is a Taiwan-based venture investment company established in 1990. The firm manages eight funds (including three biotechnology/life sciences specialty fund) representing over US$160 million of capital. CX Venture Capital Group makes investment decisions for its family of funds in both the high technology and biotechnology industries throughout North America and Asia Pacific regions. High technology investments primarily include energy, electronics, optoelectronics, communications, information technology and software. Biotechnology encompasses companies in pharmaceuticals, medical devices, bioinformatics, healthcare services and agricultural biotechnology. In addition to the provision of capital, CX Venture Capital Group assists its portfolio companies to develop corporate strategy, bridge strategic alliances, and recruit key management personnel
| Company | Date | Round | Size | Participants |
| Cellerant Therapeutics | 5/05 | Series B | $16M | 4 |
